p27(KIP1 )phosphorylation by PKB/Akt leads to poor breast cancer prognosis

por Clarke, Robert B
Publicado 2003

Complementary yet distinct roles for oestrogen receptor-α and oestrogen receptor-β in mouse mammary epithelial proliferation

por Clarke, Robert B
Publicado 2004

Epithelial stem cells in the mammary gland: casting light into dark corners

por Anderson, Elizabeth, Clarke , Robert B
Publicado 1999

22nd Annual San Antonio Breast Cancer Symposium, 8-11 December 1999, San Antonio, Texas, USA

por Clarke, Robert B, Anderson, Elizabeth
Publicado 2000

Combining Notch inhibition with current therapies for breast cancer treatment

por Brennan, Keith, Clarke, Robert B.
Publicado 2013

Do early premalignant changes in normal breast epithelial cells predict cancer development?

por Clarke, Robert B, Bundred, Nigel J
Publicado 2005

Regulation of human breast epithelial stem cells

por Clarke, Robert B., Anderson, Elizabeth, Howell, Anthony, Potten, Christopher S.
Publicado en Cell Prolif (2003)

‘The charmingest place’: non-coding RNA, lineage tracing, tumor heterogeneity, metastasis and metabolism - new methods in mammary gland development and cancer: the fifth ENBDC Work...

por Clarke, Robert B, Stingl, John, Vivanco, Maria, Bentires-Alj, Mohamed
Publicado 2013

Co-ordination of cell cycle, migration and stem cell-like activity in breast cancer

por Lamb, Rebecca, Lisanti, Michael P., Clarke, Robert B., Landberg, Göran
Publicado 2014

A Role for Notch Signalling in Breast Cancer and Endocrine Resistance

por Acar, Ahmet, Simões, Bruno M., Clarke, Robert B., Brennan, Keith
Publicado en Stem Cells Int (2016)

High-throughput genomic technology in research and clinical management of breast cancer. Exploiting the potential of gene expression profiling: is it ready for the clinic?

por Sims, Andrew H, Ong, Kai Ren, Clarke, Robert B, Howell, Anthony
Publicado 2006

Combined Inhibition of ErbB1/2 and Notch Receptors Effectively Targets Breast Ductal Carcinoma In Situ (DCIS) Stem/Progenitor Cell Activity Regardless of ErbB2 Status

por Farnie, Gillian, Willan, Pamela M., Clarke, Robert B., Bundred, Nigel J.
Publicado 2013

Cell cycle regulators cyclin D1 and CDK4/6 have estrogen receptor-dependent divergent functions in breast cancer migration and stem cell-like activity

por Lamb, Rebecca, Lehn, Sophie, Rogerson, Lynsey, Clarke, Robert B, Landberg, Göran
Publicado 2013

Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity

por Howell, Sacha J, Anderson, Elizabeth, Hunter, Tom, Farnie, Gillian, Clarke, Robert B
Publicado 2008

It's all in the details: methods in breast development and cancer

por Bentires-Alj, Mohamed, Clarke, Robert B, Jonkers, Jos, Smalley, Matthew, Stein, Torsten
Publicado 2009

The devil is in the methods: lineage tracing, functional screens and sequencing, hormones, tumour-stroma interactions, and expansion of human breast tumours as xenografts

por dM Vivanco, María, Stingl, John, Clarke, Robert B, Bentires-Alj, Mohamed
Publicado 2011

The Role of Steroid Hormones in Breast and Effects on Cancer Stem Cells

por Alferez, Denis G., Simões, Bruno M., Howell, Sacha J., Clarke, Robert B.
Publicado en Curr Stem Cell Rep (2018)

Lapatinib inhibits stem/progenitor proliferation in preclinical in vitro models of ductal carcinoma in situ (DCIS)

por Farnie, Gillian, Johnson, Rachael L, Williams, Kathryn E, Clarke, Robert B, Bundred, Nigel J
Publicado 2014

A differential role for CXCR4 in the regulation of normal versus malignant breast stem cell activity

por Ablett, Matthew P., O'Brien, Ciara S., Sims, Andrew H., Farnie, Gillian, Clarke, Robert B.
Publicado 2013

Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells

por Singh, Jagdeep K, Simões, Bruno M, Howell, Sacha J, Farnie, Gillian, Clarke, Robert B
Publicado 2013